Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2001-6-25
pubmed:abstractText
In this study, we investigated whether overexpression of pigment epithelium-derived factor (PEDF) by gene transfer can inhibit neovascularization by testing its effect in three different models of ocular neovascularization. Intravitreous injection of an adenoviral vector encoding PEDF resulted in expression of PEDF mRNA in the eye measured by RT-PCR and increased immunohistochemical staining for PEDF protein throughout the retina. In mice with laser-induced rupture of Bruch's membrane, choroidal neovascularization was significantly reduced after intravitreous injection of PEDF vector compared to injection of null vector or no injection. Subretinal injection of the PEDF vector resulted in prominent staining for PEDF in retinal pigmented epithelial cells and strong inhibition of choroidal neovascularization. In two models of retinal neovascularization (transgenic mice with increased expression of vascular endothelial growth factor (VEGF) in photoreceptors and mice with oxygen-induced ischemic retinopathy), intravitreous injection of null vector resulted in decreased neovascularization compared to no injection, but intravitreous injection of PEDF vector resulted in further inhibition of neovascularization that was statistically significant. These data suggest that sustained increased intraocular expression of PEDF by gene therapy might provide a promising approach for treatment of ocular neovascularization.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0021-9541
pubmed:author
pubmed:copyrightInfo
Copyright 2001 Wiley-Liss, Inc.
pubmed:issnType
Print
pubmed:volume
188
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
253-63
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:11424092-Adenoviridae, pubmed-meshheading:11424092-Animals, pubmed-meshheading:11424092-Antibodies, pubmed-meshheading:11424092-Aqueous Humor, pubmed-meshheading:11424092-Choroid, pubmed-meshheading:11424092-Endothelial Growth Factors, pubmed-meshheading:11424092-Eye Proteins, pubmed-meshheading:11424092-Gene Expression, pubmed-meshheading:11424092-Gene Transfer Techniques, pubmed-meshheading:11424092-Humans, pubmed-meshheading:11424092-Immunohistochemistry, pubmed-meshheading:11424092-Lymphokines, pubmed-meshheading:11424092-Mice, pubmed-meshheading:11424092-Mice, Inbred C57BL, pubmed-meshheading:11424092-Mice, Transgenic, pubmed-meshheading:11424092-Neovascularization, Physiologic, pubmed-meshheading:11424092-Nerve Growth Factors, pubmed-meshheading:11424092-Proteins, pubmed-meshheading:11424092-RNA, Messenger, pubmed-meshheading:11424092-Rabbits, pubmed-meshheading:11424092-Retina, pubmed-meshheading:11424092-Serpins, pubmed-meshheading:11424092-Vascular Endothelial Growth Factor A, pubmed-meshheading:11424092-Vascular Endothelial Growth Factors
pubmed:year
2001
pubmed:articleTitle
Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization.
pubmed:affiliation
The Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't